MicroRNA-375 inhibits colorectal cancer growth by targeting PIK3CA

被引:97
|
作者
Wang, Yihui [1 ]
Tang, Qingchao [2 ]
Li, Mingqi [1 ]
Jiang, Shixiong [1 ]
Wang, Xishan [2 ]
机构
[1] Harbin Med Univ, Affiliated Hosp 3, Dept Colorectal Surg, Harbin 150081, Peoples R China
[2] Harbin Med Univ, Affiliated Hosp 2, Ctr Canc, Harbin 150086, Peoples R China
关键词
miR-375; Colorectal cancer; PIK3CA; PI3K; Akt; PI3K-AKT PATHWAY; DOWN-REGULATION; GASTRIC-CANCER; MIR-375; PROTEIN; CELLS; PROGRESSION; EXPRESSION; NEOPLASIA; CARCINOMA;
D O I
10.1016/j.bbrc.2014.01.028
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Colorectal cancer (CRC) is the second most common cause of death from cancer. MicroRNAs (miRNAs) represent a class of small non-coding RNAs that control gene expression by triggering RNA degradation or interfering with translation. Aberrant miRNA expression is involved in human disease including cancer. Herein, we showed that miR-375 was frequently down-regulated in human colorectal cancer cell lines and tissues when compared to normal human colon tissues. PIK3CA was identified as a potential miR-375 target by bioinformatics. Overexpression of miR-375 in SW480 and HCT15 cells reduced PIIGCA protein expression. Subsequently, using reporter constructs, we showed that the PIK3CA untranslated region (3'-UTR) carries the directly binding site of miR-375. Additionally, miR-375 suppressed CRC cell proliferation and colony formation and led to cell cycle arrest. Furthermore, miR-375 overexpression resulted in inhibition of phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway. SiRNA-mediated silencing of PIK3CA blocked the inhibitory effect of miR-375 on CRC cell growth. Lastly, we found overexpressed miR-375 effectively repressed tumor growth in xenograft animal experiments. Taken together, we propose that overexpression of miR-375 may provide a selective growth inhibition for CRC cells by targeting PI3K/Akt signaling pathway. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:199 / 204
页数:6
相关论文
共 50 条
  • [1] MicroRNA-375 functions as a tumor suppressor in osteosarcoma by targeting PIK3CA
    Shi, Zhi-cai
    Chu, Xue-rong
    Wu, Yun-gang
    Wu, Jin-hui
    Lu, Chun-wen
    Lu, Run-xiao
    Ding, Mu-chen
    Mao, Ning-fang
    [J]. TUMOR BIOLOGY, 2015, 36 (11) : 8579 - 8584
  • [2] PIK3CA in colorectal cancer
    Cathomas, Gieri
    [J]. FRONTIERS IN ONCOLOGY, 2014, 4
  • [3] MicroRNA-375 suppresses human colorectal cancer metastasis by targeting Frizzled 8
    Xu, Lingling
    Wen, Tao
    Liu, Zhe
    Xu, Feng
    Yang, Lei
    Liu, Jian
    Feng, Guosheng
    An, Guangyu
    [J]. ONCOTARGET, 2016, 7 (26) : 40644 - 40656
  • [4] The Landscape of PIK3CA Mutations in Colorectal Cancer
    Voutsadakis, Ioannis A.
    [J]. CLINICAL COLORECTAL CANCER, 2021, 20 (03) : 201 - 215
  • [5] Aspirin and PIK3CA Mutations in Colorectal Cancer
    Kirstein, M. M.
    Vogel, A.
    [J]. ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2014, 52 (03): : 306 - 307
  • [6] Targeting PIK3CA pathway
    Baselga, J.
    [J]. BREAST, 2015, 24 : S10 - S10
  • [7] Targeting glutamine metabolism in PIK3CA mutant colorectal cancers
    Feng, Xiujing
    Hao, Yujun
    Wang, Zhenghe
    [J]. GENES & DISEASES, 2016, 3 (04) : 241 - 243
  • [8] Targeting glutamine addiction of PIK3CA mutant colorectal cancers
    Zhao, Yiqing
    [J]. CANCER RESEARCH, 2017, 77
  • [9] MicroRNA-375 inhibits the growth, drug sensitivity and metastasis of human ovarian cancer cells by targeting PAX2
    Yang, Shuli
    Yang, Ruiqi
    Lin, Ruixin
    Si, Lihui
    [J]. JOURNAL OF BUON, 2019, 24 (06): : 2341 - 2346
  • [10] PIK3CA mutation and colorectal cancer precision medicine
    Hamada, Tsuyoshi
    Nowak, Jonathan A.
    Ogino, Shuji
    [J]. ONCOTARGET, 2017, 8 (14) : 22305 - 22306